Valeo Wellbeing Technologies DMCC

Based in Dubai, United Arab Emirates, and founded in 2021 by its CEO, Sundeep Sahni, COO, Nadine Karadag, and CPO, Rishabh Gupta, Valeo Wellbeing Technologies DMCC, operates as a provider of a personalized mobile health tracker that enables users to schedule home blood collection, receive blood tests, and track health records. In March 2025, Valeo Wellbeing Technologies DMCC raised USD 12 million in series B funding led by new investor Flintera, with participation from other new investors Oraseya Capital and Eirad Group. Returning investors Nuwa Capital, FJ Labs, Oryx and Mindshift Capital also participated in the round. Valeo offers various healthcare services that include therapeutic solutions like IV NAD+, IV Immunity Boost, cardIV, IV Vitamin C, IV Skin Glow, IV Liver Detox, IV Energy Boost, IV Fitness, and IV Stress Relief.

The company also provides home testing services, including an advanced male blood test, a cardiac blood test, a male weight loss blood test, an advanced female blood test, a PCOS blood test, a female weight loss blood test, and many more custom blood tests. It also offers various supplement products, like Testobooster Bundle, Berberine+, Tribulus+, and many more, used for sexual health. The company generates revenue by selling various health supplements that range from AED 125 to AED 299. The company will use the March 2025 funding to accelerate the company’s mission to make personalised, science-backed healthcare solutions more accessible across the KSA, UAE and the rest of the GCC.